Literature DB >> 25332583

Erythroleukemia Presenting as Non-immune Haemolytic Anemia: A Rare Presentation.

Aastha Gupta1, Swasti Sinha1, Shyam Aggarwal2, M Bhargava1.   

Abstract

Non-immune haemolysis is a rare manifestation of acute leukaemia and more so in acute myeloid leukemia. Here, we report a case of non-immune and non-fragmentation haemolysis as the initial presenting manifestation in a 55-year-old female with acute myeloid leukaemia (AML-M6). All other potential aetiologies of haemolysis were excluded, including drugs, paroxysmal nocturnal haemoglobinuria, immune and other known congenital and acquired causes of haemolytic anaemia. This case shows that malignant haematopoietic disorders should be considered in patients with newly diagnosed haemolysis.

Entities:  

Keywords:  Acute Myeloid Leukemia; Erythroleukemia; Non-immune haemolysis

Year:  2014        PMID: 25332583      PMCID: PMC4192247          DOI: 10.1007/s12288-014-0335-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

1.  Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases.

Authors:  Ulrich J H Sachs; Lida Röder; Sentot Santoso; Gregor Bein
Journal:  Br J Haematol       Date:  2006-03       Impact factor: 6.998

2.  Severe hemolysis as presenting sign of acute erythroleukemia.

Authors:  Armin Zebisch; Heinz Sill
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

3.  Acquired beta thalassaemia trait in MDS.

Authors:  C Hoyle; J Kaeda; J Leslie; L Luzzatto
Journal:  Br J Haematol       Date:  1991-09       Impact factor: 6.998

4.  Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.

Authors:  Toyomi Kamesaki; Tomonori Toyotsuji; Eiji Kajii
Journal:  Am J Hematol       Date:  2012-11-21       Impact factor: 10.047

Review 5.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 6.  Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies.

Authors:  David P Steensma; Richard J Gibbons; Douglas R Higgs
Journal:  Blood       Date:  2004-09-09       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.